Literature DB >> 30286011

Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification.

Daishi Morimoto, Suguru Yamada, Kenta Murotani1, Fuminori Sonohara, Hideki Takami, Masaya Suenaga, Masamichi Hayashi, Yukiko Niwa, Mitsuru Tashiro, Norifumi Hattori, Naoki Iwata, Mitsuro Kanda, Chie Tanaka, Daisuke Kobayashi, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Tsutomu Fujii2, Yasuhiro Kodera.   

Abstract

OBJECTIVES: This study aimed to clarify the correlation between image classification and the pathological degree of portal system invasion (PSI) and to evaluate the prognostic impact of PSI in pancreatic cancer (PC).
METHODS: Pancreatic cancer patients with surgical resections (head, n = 244; body and tail, n = 80) were enrolled in this study.
RESULTS: Based on imaging findings, portal vein (PV) invasion was classified as type A (absent), B (unilateral narrowing), C (bilateral narrowing), or D (stenosis or obstruction with collaterals). Splenic vein (SPV) invasion was classified as type α (absent), β (stenosis), or γ (obstruction). The pathological grade of venous invasion was classified as grade 0 (no invasion), 1 (tunica adventitia), 2 (tunica media), or 3 (tunica intima). In PV and SPV invasions, image classification and pathological grade showed significant correlation (PV: ρ = 0.696; SPV: ρ = 0.681). Patients with PV invasion deeper than type B exhibited significantly poorer survival than type A (P < 0.0001). In contrast, there was no difference in survival among types α, β, and γ.
CONCLUSIONS: Image classification was correlated with the pathological grade of PSI in PC. Although not applicable for SPV invasion, image classification of PV invasion is a robust indicator for PC prognosis.

Entities:  

Mesh:

Year:  2018        PMID: 30286011     DOI: 10.1097/MPA.0000000000001186

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  3 in total

1.  Ratio of CA19-9 level to total bilirubin as a novel prognostic indicator in patients with pancreatic head carcinoma following curative resection.

Authors:  Wen-Li Xu; Jing Wang; Shao-Cheng Lyu; Lin Zhou; Qiang He; Ren Lang
Journal:  Gland Surg       Date:  2021-03

2.  Transducin-Like Enhancer of Split-1 Inhibits Malignant Behaviors in vitro and Predicts a Better Prognosis in Pancreatic Ductal Adenocarcinoma.

Authors:  Yizhi Wang; Da Yuan; Li Zhou; Zhiyong Liang; Weixun Zhou; Jun Lu; Bolun Jiang; Lei You; Junchao Guo; Yu-Pei Zhao
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

3.  Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.

Authors:  Chao Wu; Sheng Zhong Hou; Zuowei Wu; Xing Huang; Zihe Wang; Bole Tian
Journal:  BMC Cancer       Date:  2021-05-27       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.